Mira Pharmaceuticals (STU:K6S) Ending Cash Position : €2.71 Mil (As of Dec. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Mira Pharmaceuticals Ending Cash Position?

Mira Pharmaceuticals's Ending Cash Position for the quarter that ended in Dec. 2024 was €2.71 Mil.

Mira Pharmaceuticals's quarterly Ending Cash Position increased from Jun. 2024 (€2.62 Mil) to Sep. 2024 (€3.74 Mil) but then declined from Sep. 2024 (€3.74 Mil) to Dec. 2024 (€2.71 Mil).

Mira Pharmaceuticals's annual Ending Cash Position increased from Dec. 2022 (€0.33 Mil) to Dec. 2023 (€4.22 Mil) but then declined from Dec. 2023 (€4.22 Mil) to Dec. 2024 (€2.71 Mil).

Mira Pharmaceuticals Ending Cash Position Historical Data

The historical data trend for Mira Pharmaceuticals's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mira Pharmaceuticals Ending Cash Position Chart

Mira Pharmaceuticals Annual Data

Trend

Dec21

Dec22

Dec23

Dec24

Ending Cash Position

2.49

0.33

4.22

2.71

Mira Pharmaceuticals Quarterly Data
	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Ending Cash Position	Get a 7-Day Free Trial								4.22	3.25	2.62	3.74	2.71

Mira Pharmaceuticals Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Mira Pharmaceuticals's Ending Cash Position for the fiscal year that ended in Dec. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	4.397	+	-1.691
	=	2.71

Mira Pharmaceuticals's Ending Cash Position for the quarter that ended in Dec. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	3.959	+	-1.253
	=	2.71

Mira Pharmaceuticals Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Mira Pharmaceuticals's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Mira Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mira Pharmaceuticals Inc (STU:K6S) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

MIRA:USA

Address

1200 Brickell Avenue, Suite 1950 No. 1183, Miami, FL, USA, 33133

Website

https://www.mirapharmaceuticals.com

Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.

Mira Pharmaceuticals Headlines

No Headlines